Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
142.45
-3.4 (-2.33%)
BSENSE

Dec 05

BSE+NSE Vol: 59.02 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Net Sales
364.91
332.62
301.36
278.36
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
364.91
332.62
301.36
278.36
Raw Material Cost
0.00
0.00
0.00
0.00
Purchase of Finished goods
12.73
12.26
5.31
3.56
(Increase) / Decrease In Stocks
-102.73
-21.16
11.98
4.99
Employee Cost
32.50
28.25
23.32
24.78
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
225.55
142.47
117.32
115.42
Selling and Distribution Expenses
116.97
93.00
70.83
68.38
Other Expenses
30.09
27.94
23.86
24.05
Total Expenditure (Excl Depreciation)
315.11
282.76
252.62
241.18
Operating Profit (PBDIT) excl Other Income
49.80
49.86
48.74
37.18
Other Income
4.55
0.63
0.55
1.85
Operating Profit (PBDIT)
54.35
50.49
49.29
39.03
Interest
10.48
9.11
10.12
10.61
Exceptional Items
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
43.87
41.38
39.17
-60.36
Depreciation
3.82
3.26
3.01
3.08
Profit Before Tax
40.04
38.12
36.16
-63.43
Tax
1.98
1.95
1.15
3.95
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
38.06
36.17
35.01
-67.39
Extraordinary Items
0.54
3.45
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
38.60
39.62
35.01
-67.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.02
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
38.60
39.62
35.03
-67.38
Equity Capital
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
Reserves
625.38
590.91
554.17
526.94
Earnings per share (EPS)
20.32
20.85
18.44
-35.46
Diluted Earnings per share
20.14
21.34
18.44
-35.46
Operating Profit Margin (Excl OI)
13.65%
14.99%
16.17%
13.36%
Gross Profit Margin
12.02%
12.44%
13.0%
-21.68%
PAT Margin
10.43%
10.87%
11.62%
-24.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.71% vs 10.37% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is -2.57% vs 13.10% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -0.12% vs 2.30% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 15.04% vs -9.98% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has fallen from Mar 2024

Compare Annual Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
364.91
0
364.91
Other Operating Income
0.00
0.00
0.00
Total Operating income
364.91
0
364.91
Raw Material Cost
0.00
0
0.00
Purchase of Finished goods
12.73
0
12.73
(Increase) / Decrease In Stocks
-102.73
0
-102.73
Employee Cost
32.50
0
32.50
Power Cost
0.00
0
0.00
Manufacturing Expenses
225.55
0
225.55
Selling and Distribution Expenses
116.97
0
116.97
Other Expenses
30.09
0.00
30.09
Total Expenditure (Excl Depreciation)
315.11
0
315.11
Operating Profit (PBDIT) excl Other Income
49.80
0.00
49.80
Other Income
4.55
0
4.55
Operating Profit (PBDIT)
54.35
0
54.35
Interest
10.48
0
10.48
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
43.87
0
43.87
Depreciation
3.82
0
3.82
Profit Before Tax
40.04
0
40.04
Tax
1.98
0
1.98
Provisions and contingencies
0.00
0
0.00
Profit After Tax
38.06
0
38.06
Extraordinary Items
0.54
0
0.54
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
38.60
0
38.60
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
38.60
0
38.60
Equity Capital
19.00
0
19.00
Face Value
10.00
0
0.00
Reserves
625.38
0
625.38
Earnings per share (EPS)
20.32
0
20.32
Diluted Earnings per share
20.14
0
20.14
Operating Profit Margin (Excl OI)
13.65%
0%
0.00
13.65%
Gross Profit Margin
12.02%
0%
0.00
12.02%
PAT Margin
10.43%
0%
0.00
10.43%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 364.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.71% vs 10.37% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 38.60 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -2.57% vs 13.10% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 49.80 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -0.12% vs 2.30% in Mar 2024

Annual - Interest
Interest 10.48 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 15.04% vs -9.98% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.65%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has fallen from Mar 2024